Faculty - Profile
Home >Faculty
Dr. Remya R. S
Associate Professor
Department of Pharmaceutical Chemistry
- Email.id : remyars86@gmail.com
Overview
Dr. Remya R. S is an Associate Professor specialized in Pharmaceutical Chemistry with extensive experience in pharmacy education and research. She holds a Ph.D. from The Tamil Nadu Dr. MGR Medical University, completed at C.L. Baid Metha College of Pharmacy, Chennai in August 2023. She earned her M.Pharm in Pharmaceutical Chemistry from Kerala University of Health Sciences at Government Medical College, Trivandrum in July 2013, and B. Pharm from The Tamil Nadu Dr. MGR Medical University completed at S.A. Raja Pharmacy College, Vadakkangulam in August 2007. Dr. Remya has been actively involved in teaching since 2013, contributing significantly to the academic development of pharmacy students. In addition to her teaching career, she had one year of industry experience in Corporate Research and Development (R&D) of HLL Lifecare Limited, Trivandrum which enhances her practical and research-oriented approach to pharmaceutical education. The research project she worked “Development of Coated Copper T” undertaken by HLL Lifecare Ltd, obtained a fund of 1 lakh US Dollars from “Bill and Melinda Gates Foundation”. She had experience in handling sophisticated instruments UV Visible Spectroscopy, Fourier Transform Infra-Red (FTIR) Spectroscopy, Differential Scanning Calorimeter, Universal Testing Machine and Gas Permeability Tester during her tenure in HLL R&D. She had worked on drug design software’s “Schrodinger Glide” and AutoDock Vina, QSAR software QSARINS, Molecular Dynamic Simulation tool CABS-flex and Statistical Tools Graph Pad Prism and SPSS. She is a topper in NPTEL Swayam exam for “Wild Life Ecology” with gold medal and a Score of 99%. She had qualified GATE 2008 and obtained 17th Rank in All Kerala M-Pharm Entrance Examination 2010.
Google Scholar: https://scholar.google.com/citations?user=x8dIiPEAAAAJ&hl=en
Scopus Indexed: 13, JCR Indexed: 5, H-Index: 4, i10 index: 2, Citations: 59
1) Novel Therapeutic Targets in Alzheimer’s Disease: Exploring Their Roles and Mechanistic Applications, Indrakumar S, Remya R.S., Dibenthiran S., Ramalakshmi N. and Nalini C.N Current Molecular Pharmacology (Elsevier Publisher),2026, (Accepted for publication) Impact Factor:2.9, Scopus Cite Score: 5.5
2) A Systematic Review on Isoquinoline Derivatives as Emerging Multi-target Agents in Alzheimer’s and Parkinson’s Disorder Therapy Indrakumar S, Remya R.S., Dibenthiran S., Ramalakshmi N. and Nalini C.N. Central Nervous System Agents in Medicinal Chemistry. (Bentham Science Publishers), 2026, DOI: 10.2174/0118715249401454260108062419 I, (Accepted for publication) Impact Factor: 1.45, Scopus cite score: 2.6
3) Benzimidazole Conjugates as Multi-target Anticancer Agents-A Comprehensive Review., RS Remya, N Ramalakshmi, MG Safiya Aaliya MS, Blossom Concilia W, Thasneem SF, Rohini S, Narmadha N. Medicinal Chemistry (Bentham Science Publishers) . 2025 Mar;21(3):169-94. Impact Factor: 2.6 , Scopus Cite score: 4.5
4) Pyrazolo-Pyrimidines as Targeted Anticancer Scaffolds-A Comprehensive Review , Kesavamoorthy K, Remya R S, Pradeep Kumar.V, Medicinal chemistry (Bentham Science Publishers), 2023 Oct 25. doi: 10.2174/0115734064251256231018104623. Epub ahead of print. PMID: 37885114. Impact Factor: 2.6 , Scopus Cite score: 4.5
5) Design, Synthesis, and Pharmacological Evaluation of Novel Tacrine Derivatives as Multi-target ANTI-Alzheimer’s Agents In Rat Models, Central Nervous System Agents in Medicinal Chemistry, (Bentham Science Publishers), 2023 Sep 21. Doi: 10.2174/1871524923666230908094645 . Impact Factor: 1.45, Scopus cite score: 2.6
6) Design, Synthesis, Evaluation, and Toxicity Studies of Novel Acridine Derivatives in Zebra Fish Larvae , Remya R S , Ramalakshmi N, Nalini C N, Current Bioactive compounds, (Bentham Science Publishers), 2023, DOI: 10.2174/0115734072256561231008183612 . Impact factor: 1.22, Scopus cite score: 2.0
7) 2D QSAR Modelling, Docking, Synthesis and Evaluation of 2-substituted Benzimidazole Derivatives as Anti-breast Cancer Agents. Remya R S, Bharath Ramesh, Ruban Ramesh, Jaitharasan Venkatesan, Current Bioactive compounds (Bentham Science Publishers), 2023, DOI: 10.2174/0115734072255749230928060834. Impact factor: 1.22, Scopus cite score: 2.0
8) 2D-QSAR Modeling, Docking, Synthesis and In-Vitro Evaluation of Novel Flavone Derivatives as Anticancer Agents, Remya R S, Pavithra Palanikarasu, Current Bioactive compounds (Bentham Science Publishers), 2023, Article ID: e220523217153, DOI: 10.2174/1573407219666230522112102. Impact factor: 1.22, Scopus cite score: 2.0
9) Design synthesis and in vitro evaluation of Tacrine-Flavone hybrids as Multifunctional Cholinesterase inhibitors for Alzheimer’s disease., RS Remya, N Ramalakshmi, CN Nalini, V Niraimathi, S Amuthalakshmi, Current Computer-aided Drug Design (Bentham Science Publishers), 2022, 18 (4), 271-292, Doi: 10.2174/1389557521666210405161205 Impact factor: 1.63, Scopus cite score: 3
10) Design, synthesis, and in vitro evaluation of novel acridine derivatives as Monoamineoxidase inhibitors, RS Remya, N Ramalakshmi, CN Nalini, S Amuthalakshmi, Rasayan Journal of Chemistry, 2022, 15(4), 2318-2325. http://doi.org/10.31788/RJC.2022.1547080, Impact Factor: 0.79, Scopus cite score: 2.1
11) Chalcones and Flavones as Multifunctional Anticancer Agents- A Comprehensive Review, Pavithra Palanikarasu, Remya R S, N Ramalakshmi, Current Bioactive Compounds, (Bentham Science Publishers), 2022, Volume 18, Issue 10, 10.2174/1573407218666220404093136. Impact factor: 1.22, Scopus cite score: 2.0
12) Design, synthesis and pharmacological evaluation of novel benzimidazole derivatives as anticancer agents. Remya R S, Current Bioactive compounds, (Bentham Science Publishers), 2022, 17 (10) 10.2174/1573407217666210813144009. Impact factor: 1.22, Scopus cite score: 2.0
13) Multitarget directed ligand approaches for Alzheimer’s disease: A Comprehensive Review, Mini Reviews in Medicinal Chemistry, (Bentham Science Publishers), 2021, Ramalakshmi N, Remya R S, Nalini C N, 21 (16), 2361-2388 https://doi.org/10.2174/1389557521666210405161205 Impact Factor: 3.3, Scopus cite score: 8.5
14) Design synthesis and Biological Evaluation of Pyrazoline substituted derivatives as Anthelmintic agents, Research and Review: Drug and Drug development, 2021, 3 (1)
15) Covid 19 Drug Repurposing, World Journal of Pharmacy and Pharmaceutical Sciences 2020, 9 (11), 1140-1152 SJIF Impact factor- 7.632
16) In-Vitro Antibacterial and Antifungal Activity of a Novel series of Quinoxaline 2,3- Dione Derivatives. Journal of Pharmaceutical and Medicinal Chemistry, 2020, 6 (2), 49-67
17) Antibacterial Screening of Novel Quinazoline Derivatives, Journal of Pharmaceutical Advanced Research, 2020, 3 (11), 1054-1061
18) Design synthesis and Pharmacological evaluation of Pyrazoline substituted Benzimidazole derivatives as Antibacterial and Antifungal agents, 2020, Research & Reviews: A Journal of Pharmaceutical Science. STM journal, 2020, 11 (3), 29-41, SJIF Impact factor-6.674
19) Nutrition During COVID 19, World Journal of Pharmacy and Pharmaceutical Science 2020, 9 (11), 1187-1197 SJIF impact factor- 7.632
20) A Review on mono amine oxidase inhibitors, Journal of Pharmacy Research, 2018, 12 (6), 884 – 889
Presently handling Theory and Practical’s of Computer Aided Drug Design for II Sem M.Pharm, Department of Pharmaceutical Chemistry, Medicinal Chemistry for Third year Pharm D, Medicinal Chemistry I for IV Sem B-Pharm and Pharmaceutical Inorganic Chemistry for I Sem B.Pharm.
Handled Theory and Practical’s of Medicinal Chemistry III for VI Sem B.Pharm, Theory of Computer Aided Drug Design for VIII Sem B.Pharm, Practical’s of Pharmaceutical Organic Chemistry I and Biochemistry of BPharm II Sem and Pharmaceutical Organic Chemistry II of BPharm III Sem. Handled Pharmaceutical Chemistry II (T and P) , Human Anatomy and Physiology (T and P), Pharmaceutical Jurisprudence (T), Hospital and Clinical Pharmacy(T) and Pharmaceutics-I (T and P) for D. Pharmacy.
Guided four M.Pharm projects and two B.Pharm projects
• A Practical Book of Pharmaceutical Chemistry ISBN No: 978-93-91930 VEDA Publications. Authors: Mrs. E. Sankari, Mrs. Remya R S
• Obtained INTERNATIONAL PATENT for “A Novel Intrauterine device with Controlled Copper Release” Patent Number: WO2012/063262 A2, Patent owners: Remya R. S, Dr. Abi Santhosh Aprem, Dr Jeena Karippal
• Obtained Indonesian patent for “A Novel IUD with Controlled Copper Release” Patent Number: IDP00040577. Patent owners: Remya R.S, Dr.Abi Santhosh Aprem, Dr Jeena Karippal
• Obtained Philippines patent for “A Novel Intra uterine device with Controlled Copper Release” Patent Number: 1/2013/500806. Patent owners: Remya R.S, Dr.Abi Santhosh Aprem, Dr Jeena Karippal
• Obtained Hungarian Patent for “A Novel IUD with Controlled Copper Release” Patent Number: 230345 (Provisional Patent Number: IN 3321/ CHE/2010). Patent owners: Remya R. S, Dr. Abi Santhosh Aprem, Dr Jeena Karippal
• Obtained an UK Design Patent for “Apparatus for Performing Molecular Docking Studies” (Patent Number: 6385791)
• Obtained an Indian Design Patent for “Device for Calculating Absorbance and Drug Release” (Patent Number: 447169-001)
1. Nobel Lecture Series – 2025, R R College of Pharmacy, Bengaluru, 23/01/2026 to 6/02/2026
2. CHEMCON 2025, Sri Ramachandra institute of Higher education, Chennai, 23/06/2025
3. Emerging Recent Trends in Pharmaceuticals, Vasanthidevi Patil institute of Pharmacy, Maharashtra, 28/08/2025-2/09/2025
4. Al Driven Innovation in Drug Discovery & Emerging Technologies in Pharmacy A Global Perspective, C.L.Baid Metha College of Pharmacy, 4th to 6th August 2025
5. Fostering Resilience in Domains of Pharma Research’ C.L.Baid Metha College of Pharmacy 12th and 13th August 2024
6. Multi-omics Approach: A Paradigm Shift in Drug Discovery Society of Pharmaceutical Sciences and Research (SPSR) 7th July 2024
7. QbD in Pharmaceuticals: Current Status and Challenges, School of Pharmaceutical Sciences, Chettinad Academy, Tamilnadu. 21/06/2024
8. Exploring Pharmacovigilance: Unraveling Latest Trends and Career Pathways. Sri Sivani College of Pharmacy, Andhra Pradesh 24th May 2024
9. Stress Induced Neurodegeneration,Ramaiah university, Bangalore 25/10/ 2023
10. Exploring the Frontiers of Insilico drug discovery trends challenges and opportunities Ramaiah university, Bangalore 28/07/ 2023
11. Fostering the drug design via artificial Intelligence and sanctifying molecular docking studies Vels university, Chennai 24/07/ 2023 to 28/07/ 2023
12. Oncobiome: boon or bane in translational research, Ramaiah university, Bangalore 15/07/ 2023
13. Recent Advances in SMART Drug Delivery Systems Chettinad School of Pharmaceutical Sciences,Chennai 5/04/ 2023
14. Fundamentals of Biostatistics and Hypothesis Testing- Hands on training in SPSS Software C.L.Baid Metha College of Pharmacy, Chennai, 10/03/ 2023 and 11/03/2023
15. IPA annual convention, IPAC 2021, Ragavendra Institute of Pharmaceutical Education and Research, Andhra Pradesh, July 16th and 17th 2021.
16. CHEMCON 2019, Molecular Docking Studies in Drug discovery, Sri Ramachandra institute of Higher education, Chennai, 26/02/2019 and 27/02/2019
17. QbD and SixSigma in Pharma Sector- Tools, Perspective and Challenges, C.L.Baid Metha College of Pharmacy,21 and 22nd June 2019
18. Research Methodology and Biostatistics: How to do a good dissertation and Publish? The Tamilnadu Dr. M.G.R Medical University, Chennai, 6/11/2019 to 8/11/2019
19. Drug Design (D2 Part II) SRM college of Pharmacy, Kattankulathur, 3rd and 4th October 2019
20. CHEMCON 2017, Sri Ramachandra institute of Higher education, Chenna, i13/07/2017 and14/07/2017
21. Industrial Perspectives in Analytical Techniques and Training on Chemometrics Software, C.L Baid Metha College of Pharmacy, Chennai 15/09/2017 and 16/09/2017
22. Presented an e-poster titled “Design, Synthesis and Pharmacological evaluation of novel acridine derivatives as multitarget Antialzheimer’s agents” in the international conference ‘Exploring the frontiers of Insilico Drug discovery trends Challenges and opportunities’ organized by RAMAIAH University on 28th July 2023
23. Presented an e-poster entitled “Design synthesis and Pharmacological evaluation of multi-target directed ligands for Alzheimer’s disease’ in IPA annual convention, IPAC 2021
24. Presented an e-poster entitled “Design synthesis and pharmacological evaluation of novel Acridine derivatives as multitarget MAO and Cholinesterase inhibitors.” in National Pharma research e-poster competition conducted by C.L. Baid Metha College of Pharmacy, Chennai in association with IPA
• Qualified GATE 2008.
• Obtained 17th Rank in All Kerala M-Pharm Entrance Examination 2010
• Topper in NPTEL Swayam Exam for “Wild Life Ecology” with gold medal and a Score of 99%
• College Topper in B-Pharm Final Year with Distinction (2007)
• Obtained a Research fund of 1 lakh US Dollars from “Bill and Melinda Gates Foundation” on November 2010 for the project “Development of Coated Copper T” undertaken by HLL Lifecare Ltd. (Our research team headed by Dr. Abi Santhosh Aprem (Principal Investigator) obtained the fund, Co investigators: Remya R S, Jeena Jose Karippal)
• Reviewer for the journals Future Journal of Pharmaceutical Sciences (Springer Nature Link) and Scientific African. (Science Direct/Elsevier)